Inc. today announced the issuance of US Patent No. 7,399,429 covering the
ability to make semiconductor nanocrystals from III-V materials, including indium
galium phosphide. This newly issued patent represents a dramatic increase in
the advancement of semiconductor materials science and augments the breadth
of the company's intellectual property portfolio.
"The issuance of this key patent underscores the fact that Evident Technologies,
Inc. remains a pioneer in the development of novel and proprietary semiconductor
nanocrystals, and affords us broad protection in a rapidly growing segment of
the market," stated Clint Ballinger Ph.D., CEO of Evident Technologies.
"In response to a growing industry demand, our scientists have worked diligently
over the past several years to develop new bright, stable III-V material systems."
Evident Technologies' broad array of semiconductor nanocrystal materials are
already used in many industries around the world in products ranging from electronics
to life science reagents. Companies and research institutes alike can benefit
from this new, patented technology and continue the development of quantum dot
applications from energy conversion to LEDs to life science.
"The unique spectral properties of these III-V quantum dot nanocrystals
include absorption in the ultraviolet through the near-infrared range and emission
in the near-infrared range, and are ideal for several applications within the
life sciences," said Todd R. Nelson Ph.D., CEO of eBioscience, the worldwide,
exclusive licensee of this technology within the life sciences industry. "We
believe our customers will find that the products enabled by this technology
will represent a significant advancement in multicolor applications, and will
allow us to develop the next generation of eFluor in-vivo imaging reagents."